http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#Head http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#assertion http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#provenance http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#pubinfo http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#assertion http://purl.obolibrary.org/obo/MONDO_0005452 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/MONDO_0005452 http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://go.drugbank.com/drugs/DB01255 http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association http://www.w3.org/2000/01/rdf-schema#label Of relevance, lisdexamfetamine dimesylate, a psy- chostimulant approved for the treatment of ADHD, has been recently assessed and approved for the treat- ment of moderate to severe binge eating disorder in adults.5,6 In a phase 2 efficacy and safety trial, pa- tients with binge eating disorder who were prescribed doses of 50 and 70 mg/day doses of lisdexamfetamine demonstrated reduced binge eating days per week, greater binge eating cessation rates, and greater rates of clinical global improvement at 11 weeks compared with the placebo control group http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association https://w3id.org/biolink/vocab/has_population_context http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#cohort http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association https://w3id.org/biolink/vocab/publications https://pubmed.ncbi.nlm.nih.gov/28125174/ http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/OffLabelIndication http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#cohort http://www.w3.org/2000/01/rdf-schema#label Adults http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#cohort https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Cohort https://go.drugbank.com/drugs/DB01255 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#provenance http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#pubinfo http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#sig http://purl.org/nanopub/x/hasSignature PCDPwKiHmsH80UaIs0rt9FS3fcNixmWn4eRPirgozVk8qKEPH2rM6RjOErxw1MP+93czBmLUs92nPOhwPM428RQjRO+Z6b3qYvi7ZV+J2BWtXOcqT76T0GLpNWQDiM6iEfOHh4SUAkg8VqFCerh+2uiXK8xnHHS3JmY/JkjXzUQ= http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI http://purl.org/dc/terms/created 2021-05-31T10:52:02.178+02:00 http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI http://purl.org/dc/terms/creator https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs